Monday: What to see, eat and do in Astoria, a food truck from Macao, and a free Citi Bike ride.
NYS Entity Status
NYS Filing Date
OCTOBER 15, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC BUSINESS CORPORATION
2013 - FOOD & DISCOUNTS WORLD INC.
AROUND THE WEB
- New York Today: New York Today: An Excursion to Astoria
By JONATHAN WOLFE - Monday Sep 18, 2017
- Food & Wine Magazine Will Leave New York for Alabama
By STEPHANIE STROM - Friday Jun 23, 2017
The move reflects a changing business in which traditional food magazines, and a Manhattan address, are less important.
- Amazon Prime members will get even deeper discounts at Whole Foods
By Valentina Palladino - Friday Aug 25, 2017
Beef, salmon, avocados, and more will be cheaper for everyone starting next week.
- Amazon Prime Members Will Get Special Discounts At Whole Foods Stores
By Laura Northrup - Thursday Aug 24, 2017
If you’ve been wondering what the marriage of Whole Foods and Amazon will look like, we now have one clue that’s more tantalizing than a bundle of young asparagus. In the companies’ official wedding announcement today, their leaders announced how they plan to open up special deals at physical Whole Foods stores to subscribers to Amazon’s Prime service, and place …
- A New Kind of Classroom: No Grades, No Failing, No Hurry
By KYLE SPENCER - Friday Aug 11, 2017
Mastery-based learning allows students to learn at their own pace.
- Abbvie’s hep C drug pricing threatens Gilead’s dominance
By Max Nisen - Tuesday Aug 8, 2017
Pharma already leads the business world in unpredictability, with billions in sales potentially riding on a few points of statistical significance in a clinical trial.[...] even within that context, a series of blockbuster medicines for hepatitis C have made for a roller-coaster ride for companies and investors.AbbVie Inc. last week threw another big curve at this market by pricing its newly FDA-approved drug Mavyret — which might be the most effective hepatitis C medicine approved yet — at a massive discount.Medicines from Johnson & Johnson, Merck & Co. Inc. and Vertex Pharmaceuticals Inc. approved within the past six years, which once booked billions in combined sales, are now essentially non-factors.After offering behind-the-scene discounts to insurance companies, pharmacy benefit managers and other payers, Mavyret’s price is actually not far from Harvoni’s, according to Bloomberg Intelligence.The real headache for Gilead — which already faces steep declines in hepatitis C drug sales because of increasing competition and the fact that many patients have been cured — lies in the fact that not all hepatitis patients or medicines are the same.AbbVie’s new drug can treat all of the major subtypes of hepatitis C. And it can cure the disease in many patients in just eight weeks.